Interní Med. 2007; 9(2): 91-95

Hypertension in pregnancy

MUDr. Petr Janků
Gynekologicko-porodnická klinika LF MU a FN Brno

The classification of hypertension in pregnancy is not unified which leads to mistakes not only in differential diagnostics but also in therapy and dispensarisation. We divide hypertension in pregnancy into preeclampsia, preexistent hypertension, preeclampsia superimposed into preexistent hypertension and gestational hypertension. Preeclampsia is a complex disease of pregnant women and hypertension is one of its substantial symptoms. It leads to serious health risks of mother and fetus. It differs in this aspect from other forms of hypertension where the risks for mother and fetus are minimal.

Keywords: Key words: preeclampsia, preexistent hypertension, gestational hypertension, arterial hypertension, secondary hypertension, pregnancy.

Published: March 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Janků P. Hypertension in pregnancy. Interní Med. 2007;9(2):91-95.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Afifi Y, Churchill D. Pharmacological treatment of hypertension in pregnancy. Current Pharmaceutical Design 2003; 9: 1745-1753. Go to original source... Go to PubMed...
    2. American College of Obstetricians and Gynecologists. Chronic hypertension in pregnancy. Obstetrics and Gynecology 2001; 98: 177-185. Go to original source...
    3. Atallah AN, Hofmeyr GJ, Duley L. Calciuum supplementation during pregnancy for preventig hypertensive disorders and related problems (Cochrane Review). Oxford 2002 The Cochrane Library. Update Software. Go to original source...
    4. Baldwin KJ, Leighton NA, Kilby MD. et al. The West Midlands, ,Severe hypertensive illness in pregnancy" (SHIP) audit. Hypertension in Pregnancy 2001; 20: 257-268. Go to original source... Go to PubMed...
    5. Beevers G, Lip GYH, O'Brien E. ABC of hypertension London. BMJ Books 4th ed. 2001.
    6. Belfort MA. Anthony J. Saade GR. et al. A comparison of magnesium sulkfate and nimodipine for the prevention of eclampsia. N Engl J Med 2003; 348: 304-311. Go to original source... Go to PubMed...
    7. Borghi C. Eposti DD. Cassani A. et al. Journal of Hypertension 2002; 20 Suppl: 52-56.
    8. Brown MA, Buddle ML, Farrell T, et al. Efficacy and safety of nifedipine tablets for the acute treatment of severe hypertension in pregnancy. Am J Obstet Gynecol 2002; 187: 1046-1050. Go to original source... Go to PubMed...
    9. Cífková R. Hypertenze v těhotenství. In: Widimský J. a kol. Hypertenze. Praha Triton 2002: 280-290.
    10. Cífková R. Hypertenze v těhotenství. Kardiol Rev (KF) 3/2004: 39-43.
    11. Cífková R, Horký K, Widimský J, sr. Widimský J. jr. Doporučení diagnostických a léčebných postupů u arteriální hypertenze - návrh verze 2004. Doporučení ČSH. Hypertenze 2004; 7: 9-24.
    12. de Groot CJ, Visser W, Steegers EA. Pregnancy and chronic hypertension: risk and policy. Nederlands tijdschrift voor geneeskunde. 2003; 147: 2281-2284.
    13. De Swiet M. Hypertension and pre-eclamptic toxemia. In: Oakley C, ed. Heart disease in pregnancy. London BMJ Publishing Group 1997: 293-306.
    14. Doporučení České společnosti pro hypertenzi: doporučení diagnostických a léčebných postupů arteriální hypertenze - verze 2004. Vnitř lék 2004; 50: 709-722. Go to PubMed...
    15. Douglas KA, Redman CWG. Eklampsia in the United Kingdom. B M J 1994; 309: 1395-1400. Go to original source... Go to PubMed...
    16. Dukát A, Korbeľ M, Sirotiaková J. et al. Hypertenzia a gravidita. Interní medicina pro praxi 2003; 5: 548-551.
    17. Duley L. Pre-eclampsia and the hypertensive disorders of pregnancy. Brit Med Bulletin 2003; 67: 161-176. Go to original source... Go to PubMed...
    18. Horký K, Widimský J, Cífková R. Doporučení diagnostických a léčebných postupů u arteriální hypertenze. In Doporučené postupy v kardiologii. ČKS I. část 1998: 59-64.
    19. Chari RS, Frangieh AY, Sibai BM. Hypertension during pregnancy. Diagnosis pathophysiology, and management. In Elkayam U, Gleicher N. eds New York Wiley-Liss 3rd ed. 1998: 257-273.
    20. Janků K. Hypertenze v těhotenství., Brno, IDVPZ, 1998, s. 170.
    21. Janků K, Unzeitig V, Roztočil A, Janků P. Hypertenze v těhotenství - chaos v názvosloví ve světové literatuře. Čs Gynek 1995; 60: 149-153.
    22. Janků K, Janků P, Unzeitig V. Hypertenze v těhotenství. Interní medicina pro praxi. 2000; 2: 21-31.
    23. Korbel' M. Havalda A, Nižnanská Z. et al. Vpliv nízkých dávok kyseliny acetylsalicylovej na priebeh preeklampsie. Slovenská gynekologia a pórodnictvo 1996; 3: 138-140.
    24. Korbeľ M, Dukát A, Redecha M, et al. Hypertenzia a gravidita z pohľadu gynekológa. Interní medicina pro praxi 2002; 2: 76-82.
    25. Král J, Hruda J, Janků K. Doporučené postupy pro diagnostiku a léčbu vybraných kardiovaskulárních onemocnění v těhotenství. In: Doporučené postupy v kardiologii. ČKS II. část 2000: 27-36.
    26. Leitich H, Egarter CH, Husslein P. et al. A meta-analysis of low dose aspirin for the prevention of intrauterine growth retardation. Br J Obstet Gynaec 1997;104: 450-459. Go to original source... Go to PubMed...
    27. Mc Elhatton PR. Heart and circulatory system drugs. In: Schaefer C. (Ed) Drugs during pregnancy and lactation. Amsterdam 2001.
    28. National Heart Lung and Blood institute. National High Blood Pressure Education Program: Working group report od high blood pressure in pregnancy. Bethesda (MD). NHLBI: 2000; s. 38. Go to original source...
    29. Ramsay L, Wiliams B, Johnston G. et al. Guidelines for management of hypertension: report of the third working party of the British Hypertension Society. J Human Hypert 1999; 13: 569-592. Go to original source... Go to PubMed...
    30. Report on confidential inquieries into maternal health in the United Kingdom 1988-1990. London HMSO, 1994.
    31. Rey E. Coutourier A. The prognosis of pregnancy in women with chronic hypertension. Am J Obstet Gynecol 1994; 171: 410-416. Go to original source... Go to PubMed...
    32. Shahnaz AB. Shahabi NS. Nifedipine or hydralazine as a first-line agent to control hypertension in severe preeclampsia. Act Obstet Gynec Scand. 2002; 81: 25-30. Go to original source... Go to PubMed...
    33. Sibai BM. Hypertensive disorders in women. Philadelphia W.B.Saunders Comp. 2001; s. 262.
    34. Vangen S. Bergsjo P. Do women die from pregnancy these days? Tidsskrift for den Norske laegeforening. 2003; 123: 3544-3545. Go to PubMed...
    35. Vidaeff AC, Barss VA. Hepatic involvement in preeclampsia. 28. mezinár. kongres o patofyziologii v těhotenství, Timisoara, Rumunsko, 22-25. 5. 1996, Sborník s. 93-111.
    36. Weisman CD, Mayorga LM, Camera LI. et al. Magnesium plus nifedipine: potentiation of hypotensive effect in pre-eclampsia. Am J Obstet Gynecol 1988; 159: 308-309. Go to original source... Go to PubMed...
    37. Widimský J. Kardiovaskulární orgánové projevy esenciální hypertenze - možnosti cílené léčby a prevence. Vnitř. lékařství 1995; 41: 403-410.
    38. Widlansky ME. Gokce N. Keaney JF. Jr. et al. The clinical implications of endothelial dysfunction. J Am Coll Cardiol 2003; 42: 1149-1160. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.